Members |
targetComponentId |
Ceftazidime 10g/vial injection |
Ceftazidime anhydrous (as ceftazidime) 10 g powder for solution for injection vial |
Ceftazidime 1g injection |
Ceftazidime 1 g powder for solution for injection vial |
Ceftazidime 1g powder for injection |
Ceftazidime 1 g powder for solution for injection vial |
Ceftazidime 1g/25mL injection |
Ceftazidime 1 g powder for solution for injection vial |
Ceftazidime 1g/vial injection |
Ceftazidime 1 g powder for solution for injection vial |
Ceftazidime 1g/vial powder |
Ceftazidime 1 g powder for solution for injection vial |
Ceftazidime 2000mg infusion solution vial |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Ceftazidime 2g injection |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Ceftazidime 2g powder |
Ceftazidime 2 g powder for solution for injection vial |
Ceftazidime 2g powder for infusion solution vial |
Ceftazidime 2 g powder for solution for injection vial |
Ceftazidime 2g/vial injection |
Ceftazidime 2 g powder for solution for injection vial |
Ceftazidime 2gm/vil powder |
Ceftazidime 2 g powder for solution for injection vial |
Ceftazidime 500mg infusion solution vial |
Ceftazidime 500 mg powder for solution for injection vial |
Ceftazidime 500mg injection |
Ceftazidime 500 mg powder for solution for injection vial |
Ceftazidime 500mg/vial injection |
Ceftazidime 500 mg powder for solution for injection vial |
Ceftazidime pentahydrate 100mg infusion solution vial |
Ceftazidime only product in parenteral dose form |
Ceftazidime pentahydrate 1g injection |
Ceftazidime only product in parenteral dose form |
Ceftazidime pentahydrate 1g/vial injection |
Ceftazidime only product in parenteral dose form |
Ceftazidime pentahydrate 2g injection |
Ceftazidime 2 g powder for solution for injection vial |
Ceftazidime pentahydrate 2g powder for injection |
Ceftazidime 2 g powder for solution for injection vial |
Ceftazidime pentahydrate 2g/vial injection |
Ceftazidime 2 g powder for solution for injection vial |
Ceftazidime pentahydrate 6g infusion solution vial |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 6 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Ceftazidime pentahydrate 6g injection |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 6 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Ceftazidime pentahydrate 6g/vial injection |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 6 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Ceftazidime sodium 1g injection |
Ceftazidime 1 g powder for solution for injection vial |
Ceftazidime sodium 1g powder for injection |
Ceftazidime 1 g powder for solution for injection vial |
Ceftazidime sodium 2g injection |
Ceftazidime 2 g powder for solution for injection vial |
Ceftazidime sodium 2g powder for injection |
Ceftazidime 2 g powder for solution for injection vial |
Ceftazidime sodium 2g/50 mL conventional release solution for infusion 50mL bag |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Ceftazidime sodium 2g/50 mL injection |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Ceftazidime sodium 2g/50 mL intravenous solution 50mL bag |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Ceftazidime sodium 2g/50mL injection |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Ceftizoxime sodium 10g powder for injection solution vial |
Product containing precisely ceftizoxime (as ceftizoxime sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Ceftizoxime sodium 1g powder for injection solution vial |
Product containing precisely ceftizoxime (as ceftizoxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Ceftizoxime sodium 2g powder for injection solution vial |
Ceftizoxime (as ceftizoxime sodium) 2 g powder for solution for injection vial |
Ceftizoxime sodium 2g/vial injection |
Ceftizoxime (as ceftizoxime sodium) 2 g powder for solution for injection vial |
Ceftizoxime sodium 500mg powder for injection solution vial |
Ceftizoxime (as ceftizoxime sodium) 500 mg powder for solution for injection vial |
Ceftriaxone sodium 10g powder for injection solution vial |
Product containing precisely ceftriaxone (as ceftriaxone sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Cefuroxime sodium 15mg/mL injection solution 50mL bag |
Product containing precisely cefuroxime (as cefuroxime sodium) 15 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Cefuroxime sodium 30mg/mL injection solution 50mL bag |
Cefuroxime (as cefuroxime sodium) 30 mg/mL solution for injection |
Celecoxib |
Celecoxib |
Celluella pygmaea |
Callithrix pygmaea (organism) |
Cellulitis of foot, except toe |
Cellulitis of foot |
Cellulitis of head, except face |
Cellulitis of head |
Cellulomonas cellulans |
Cellulosimicrobium cellulans (organism) |
Cellulomonas fermentans |
Actinotalea fermentans (organism) |
Cellulose sodium phosphate 300g/bottle powder for oral suspension |
Cellulose only product in oral dose form |
Central cervical cord injury, without bony injury, C1-4 |
Central cervical cord injury, without spinal bony injury, C1-4 (disorder) |
Central cervical cord injury, without bony injury, C5-7 |
Central cervical cord injury, without spinal bony injury, C5-7 (disorder) |
Central cord syndrome of cervical spinal cord |
Central cord syndrome |
Central respiratory stimulant |
Respiratory stimulant (substance) |
Central sleep apnea caused by substance |
Central sleep apnea syndrome |
Central venous catheter associated bloodstream infection |
Infection of bloodstream co-occurrent and due to central venous catheter in situ (disorder) |
Central venous catheter related bloodstream infection |
Infection of bloodstream co-occurrent and due to central venous catheter in situ (disorder) |
Central venous catheter: [attention] or [removal Hickman] |
Removal of central venous line |
Centruroides sculpturatus |
Centruroides exilicauda |
Cephalad pubic bone dysfunction |
Superior pubic shear (finding) |
Cephalexin 125mg/5mL syrup |
Cefalexin 25 mg/mL oral solution |
Cephalexin 250mg/5mL syrup |
Cefalexin anhydrous (as cefalexin) 50 mg/mL oral solution |
Cephalexin monohydrate 250mg capsule |
Product containing precisely cefalexin 250 milligram/1 each conventional release oral capsule (clinical drug) |
Cephalexin monohydrate 500mg capsule |
Cefalexin 500 mg oral capsule |
Cephalic presentation |
Cephalic fetal presentation |
Cephalic version |
External cephalic version |
Cephalophus doria |
Cephalophus zebra (organism) |
Cephalotrichium |
Genus Strobilidium (organism) |
Cephapirin sodium 1g powder for injection solution vial |
Product containing precisely cefapirin (as cefapirin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Cercospora apii |
Mycocentrospora acerina |
Cerebellar contusion with open intracranial wound and unspecified state of consciousness |
Cerebellar contusion with open intracranial wound |
Cerebellar contusion without open intracranial wound and with unspecified state of consciousness |
Cerebellar contusion without open intracranial wound |
Cerebellar laceration with open intracranial wound and unspecified state of consciousness |
Cerebellar laceration with open intracranial wound |
Cerebellar laceration without open intracranial wound and with unspecified state of consciousness |
Cerebellar laceration without open intracranial wound |
Cerebral degeneration |
Degenerative brain disorder |
Cerebral edema |
Cerebral edema |
syndrome de gigantisme cérébral-kystes maxillaires |
Gorlin syndrome |
Cerebrocardiac neurosis |
Neurocirculatory asthenia |
Cerebroretinal vasculopathy |
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
Cerebrovascular accident annual review |
Cerebrovascular accident annual review |
Certoparin sodium |
Product containing certoparin (medicinal product) |
Ceruloplasmin |
Ferroxidase |
Cervical approach |
Transcervical approach - uterine |
Cervical discography |
Discography with injection of contrast into intervertebral disc of cervical spine |
Cervical flap |
Flap (substance) |
Cervical region flap |
Flap (substance) |
Réalisation d'un frottis cervical |
Sampling of cervix for Papanicolaou smear done (situation) |
Cervical smear biopsy taken |
Sampling of cervix for Papanicolaou smear done (situation) |
Frottis cervical refusé |
Screening for malignant neoplasm of cervix declined (situation) |
Cervical smear refused |
Screening for malignant neoplasm of cervix declined (situation) |
Cervical smear refused |
Screening for malignant neoplasm of cervix declined (situation) |
Cervical spondylosis with myelopathy |
Myelopathy due to cervical spondylosis (disorder) |
spondylose cervicale avec myélopathie |
Myelopathy due to cervical spondylosis (disorder) |
Cervical spondylosis with radiculopathy |
Radiculopathy due to cervical spondylosis (disorder) |
Cervical syndrome, NEC |
Cervical syndrome |
Cervicitis |
Inflammation of cervix |
Cervicohumeral fasciocutaneous flap |
Fasciocutaneous flap |
Cervus elaphus bactrianus |
Cervus elaphus |
Cervus elaphus nannodes |
Cervus elaphus |
Cesarean delivery - delivered |
Deliveries by caesarean |
Cesarean delivery NOS |
Deliveries by caesarean |
Cesarean delivery unspecified |
Deliveries by caesarean |
Cesarean delivery without indication |
Cesarean section |
Cetirizine hydrochloride + pseudoephedrine 5mg/120mg m/r tablet |
Product containing only cetirizine and pseudoephedrine in oral dose form (medicinal product form) |